Suppr超能文献

草药和补充剂对非酒精性脂肪性肝病患者的潜在治疗益处。

Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD.

作者信息

Perumpail Brandon J, Li Andrew A, Iqbal Umair, Sallam Sandy, Shah Neha D, Kwong Waiyee, Cholankeril George, Kim Donghee, Ahmed Aijaz

机构信息

Drexel University College of Medicine, Philadelphia, PA 19129, USA.

Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.

出版信息

Diseases. 2018 Sep 10;6(3):80. doi: 10.3390/diseases6030080.

Abstract

Our aim is to review the efficacy of various herbs and supplements as a possible therapeutic option in the treatment and/or prevention of nonalcoholic fatty liver disease (NAFLD). We performed a systematic review of medical literature using the PubMed Database by searching the chemical names of many common herbs and supplements with "AND (NAFLD or NASH)". Studies and medical literature that discussed the roles and usage of herbs and supplements in NAFLD and nonalcoholic steatohepatitis (NASH) from inception until 20 June 2018 were reviewed. Many studies have claimed that the use of various herbs and supplements may improve disease endpoints and outcomes related to NAFLD and/or NASH. Improvement in liver function tests were noted. Amelioration or reduction of lobular inflammation, hepatic steatosis, and fibrosis were also noted. However, well-designed studies demonstrating improved clinical outcomes are lacking. Furthermore, experts remain concerned about the lack of regulation of herbs/supplements and the need for further research on potential adverse effects and herb⁻drug interactions. In conclusion, preliminary data on several herbs have demonstrated promising antioxidant, anti-inflammatory, anti-apoptotic, and anti-adipogenic properties that may help curtail the progression of NAFLD/NASH. Clinical trials testing the safety and efficacy must be completed before widespread can be recommended.

摘要

我们的目的是评估各种草药和补充剂作为治疗和/或预防非酒精性脂肪性肝病(NAFLD)的一种可能治疗选择的疗效。我们通过在PubMed数据库中搜索许多常见草药和补充剂的化学名称并结合“AND(NAFLD或NASH)”对医学文献进行了系统综述。对从开始到2018年6月20日期间讨论草药和补充剂在NAFLD和非酒精性脂肪性肝炎(NASH)中的作用和用法的研究及医学文献进行了综述。许多研究声称,使用各种草药和补充剂可能改善与NAFLD和/或NASH相关的疾病终点和结局。观察到肝功能检查有所改善。还注意到小叶炎症、肝脂肪变性和纤维化有所减轻或缓解。然而,缺乏设计良好的研究来证明临床结局得到改善。此外,专家们仍然担心草药/补充剂缺乏监管,以及需要对潜在的不良反应和草药-药物相互作用进行进一步研究。总之,关于几种草药的初步数据已显示出有前景的抗氧化、抗炎、抗凋亡和抗脂肪生成特性,这可能有助于遏制NAFLD/NASH的进展。在推荐广泛使用之前,必须完成测试安全性和疗效的临床试验。

相似文献

10
Pathology of nonalcoholic steatohepatitis.非酒精性脂肪性肝炎的病理学。
Hepatol Res. 2005 Oct;33(2):68-71. doi: 10.1016/j.hepres.2005.09.006. Epub 2005 Oct 7.

引用本文的文献

本文引用的文献

1
The Role of Cannabinoids in the Setting of Cirrhosis.大麻素在肝硬化背景下的作用
Medicines (Basel). 2018 Jun 9;5(2):52. doi: 10.3390/medicines5020052.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验